Insulin resistance and diabetic macular oedema in type 2 diabetes mellitus

British Journal of Ophthalmology

Volumn 94, Issue 9, 2010, Pages 1230-1232

  Zapata, Miguel Angel ^a   Badal, José ^a   Fonollosa, Alex ^a   Boixadera, Anna ^a   García Arumí, José ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Ocular Microsurgery Institute   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD SAMPLING; DIABETIC MACULAR EDEMA; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; MACULAR EDEMA; METABOLISM; PHYSIOLOGY;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MACULAR EDEMA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 77956605583     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.171702     Document Type: Article

References (14)

1. Gardner TW, Antonetti DA. Novel potential mechanisms for diabetic macular oedema: leveraging new investigational approaches. Current Diab Reports 2008;8:263-9.
2. Menkin V. Diabetes and inflammation. Science 1941;2419:456-8.
3. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005;115:1111-19.
4. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-801.
5. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008;582:97-105.
6. Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1 alpha and VEGF. J Clin Invest 2002;109:805-15.
7. Zapata MA, Losada E, Fonollosa A, et al. García-Arumí J. Blurred vision and increased macular volume in the introduction of insulin therapy: a prospective study. Fort Lauderdale, FL, USA: ARVO, 2007. Poster Presentation.
8. Fontbonne A, Eschwège E, Cambien F, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11 year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300-4. (Pubitemid 19166483)
9. Ascaso JF, Pardo S, Real JT, et al. Diagnosis of insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5. (Pubitemid 37466894)
10. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular oedema. Am J Ophthalmol 2006;142:405-12.
11. McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-4.
12. Martin NF, Green WR, Martin LW. Retinal phlebitis in the Irvine-Gass syndrome. Am J Ophthalmol 1977;83:377-86.
13. Ryan SJ. Retina. Volume 3. Surgical Retina. 114 Vitreoretinal Interface. 4th edn, Elsevier Inc, New York, USA. 2006.
14. Noma H, Funatsu H, Mimura T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular oedema with central retinal vein occlusion. Ophthalmology 2009;116:87-93.